News | May 09, 2011

Pioneer of Catheter-Based Aortic Valve Procedures Traces Progress

May 9, 2011 — John Webb, M.D., FSCAI, has traveled the globe teaching fellow physicians how to repair or replace faulty heart valves using minimally invasive techniques. In a keynote Founders’ Lecture delivered at the Society for Cardiovascular Angiography and Interventions (SCAI) 2011 Scientific Sessions last week, he recount the challenges that arose in developing valve therapies that avoid open-chest surgery. Instead, interventional cardiologists use slender tubes, or catheters, that are threaded into the heart through blood vessels.

“When we started, we thought it was very possible that a transcatheter valve procedure could be developed and could be reproducible, but with no experience, nobody really knew for sure,” said Webb, the McCleod Professor of Heart Valve Intervention at the University of British Columbia in Vancouver.

In his Founders’ Lecture, Webb focused primarily on catheter procedures used to implant new aortic valves, the valve that controls the flow of blood from the heart to the rest of the body. He also addressed the development of transcatheter implantation of pulmonary valves (between the heart and lungs) and mitral valves (between the upper and lower chambers on the left side of the heart). In addition, Webb presented advances in catheter techniques for implanting replacement valves inside artificial valves that have failed after open-chest surgery.

The first catheter procedures to treat constricted aortic valves were being performed just as Webb was beginning his training in interventional cardiology. He became interested in how to improve the technique by doing more than just stretching the calcified aortic valve with a balloon. But the idea of an implantable valve was dismissed by skeptics as too far-fetched.

Refining the technique took many years, said Webb, who has since performed or mentored more than a thousand catheter-based aortic valve replacements in 20 countries.

“With time, as each new problem was identified, we were able to take a careful look at it and analyze it and come up with a way of managing these patients so that these complications would be less likely,” he said. “It was really a story of incremental improvements in the technique and patient selection and the device.”

It was not until about 2006 that Webb became convinced that implantation of an aortic valve with a catheter would become a common procedure. Though practical obstacles still exist, he is confident they can be overcome. He continues to welcome cardiovascular teams to the University of British Columbia for intensive training in the procedure.

For more information: www.scai.org

Related Content

Boston Scientific, Edwards Lifesciences Agree To Global Litigation Settlement
News | Heart Valve Technology | January 15, 2019
Boston Scientific Corp. and Edwards Lifesciences Corp. announced that the companies have reached an agreement to settle...
The implantation of a MitraClip is guided under live transesophageal echo (TEE). This image shows the operator moving the open clip into position and engaging the mitral valve leaflets. The clip appears as a arrowhead shape in the ultrasound with the leaflets coming off each side. Photo from a MitraClip procedure at the University of Colorado Hospital. Dr. Dominick Wiktor. The TEE is from a Philips Epiq system.

The implantation of a MitraClip is guided under live transesophageal echo (TEE). This image shows the operator moving the open clip into position and engaging the mitral valve leaflets. The clip appears as an arrowhead shape in the ultrasound with the leaflets coming off each side. Photo from a MitraClip procedure at the University of Colorado Hospital.

Feature | Heart Valve Technology | January 14, 2019 | Allen Atchley, M.D., FACC, The Chattanooga Heart Institute
Mitral regurgitation (MR) is one of the most common types of heart valve diseases in the United States, affecting app
JC Medical Announces First U.S. Treatment With J-Valve TAVR Device
News | Heart Valve Technology | January 07, 2019
January 7, 2019 — JC Medical announced the successful treatment of the first U.S.
Edwards' Sapien 3 Ultra Transcatheter Heart Valve Receives FDA Approval
Technology | Heart Valve Technology | January 02, 2019
Edwards Lifesciences Corp. announced that the Sapien 3 Ultra system has received U.S. Food and Drug Administration (FDA...
Boston Scientific Prevails in U.S. Edwards Lifesciences Litigation
Feature | Heart Valve Technology | December 12, 2018
A jury in the U.S. District Court for the District of Delaware determined Dec. 11 that the Boston Scientific U.S....
First TriCinch Coil Tricuspid Repair Systems Implanted in U.S.
News | Heart Valve Technology | November 06, 2018
4Tech Inc. initiated its U.S. Early Feasibility Study of the TriCinich Coil System following U.S. Food and Drug...
Valve Replacement Volume Key to Successful Patient Outcomes
News | Heart Valve Technology | November 02, 2018
Hospitals that routinely perform a heart valve replacement procedure requiring open heart surgery are more likely to...
Prosthetic Valve Mismatches Common in TAVR Procedures
News | Heart Valve Technology | October 03, 2018
A high number of patients in a study who underwent transcatheter aortic valve replacement (TAVR) experienced severe and...
Local Anesthesia Safe and Effective for Intermediate- and High-Risk TAVR Patients
News | Heart Valve Technology | September 28, 2018
The first randomized study to compare general versus local anesthesia during transcatheter aortic valve replacement (...
Overlay Init